BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/14/2023 1:45:13 PM | Browse: 265 | Download: 558
 |
Received |
|
2022-09-15 18:54 |
|
Peer-Review Started |
|
2022-09-15 18:55 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-01-03 21:47 |
|
Revised |
|
2023-01-25 14:13 |
|
Second Decision |
|
2023-03-08 03:11 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-03-14 17:36 |
|
Articles in Press |
|
2023-03-14 17:36 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-03-21 02:16 |
|
Typeset the Manuscript |
|
2023-04-11 06:31 |
|
Publish the Manuscript Online |
|
2023-04-14 13:45 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Immunotherapy for recurrent hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ahan Bhatt and Jennifer Wu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jennifer Wu, MD, Associate Professor, Attending Doctor, Division of Hematology and Oncology, Perlmutter Cancer Center of NYU Langone Health, NYU School of Medicine, 462 First Ave, BCD556, New York, NY 10016, New York, NY 10016, United States. jennifer.wu@nyulangone.org |
| Key Words |
Immunotherapy; Hepatocellular carcinoma; Liver cancer |
| Core Tip |
Immunotherapy has made a strong headway in the management of hepatocellular carcinoma (HCC). For patients who recur on local therapy, immunotherapy has become the standard of care treatment option for unresectable HCC. Role of immunotherapy agents is still not explored in patients who progress on prior immunotherapy. This mini-review highlights the various treatment options available in clinical practice as well as upcoming novel management strategies in recurrent HCC. |
| Publish Date |
2023-04-14 13:45 |
| Citation |
Bhatt A, Wu J. Immunotherapy for recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29(15): 2261-2271 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i15/2261.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i15.2261 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
